Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 29-03 / BIG 3-98 

A survey to assess the attitude of patients aged less than 35 years, with early breast cancer, towards the risk of loss of fertility related to adjuvant therapies.

DESIGN

Design Trial 29-03

Study Chairs
Dr. Olivia Pagani - Mendrisio, Switzerland
Dr. Laura Orlando - Milano, Italy

Trial Coordinator
Susanne Roux
IBCSG Coordinating Center, Bern, Switzerland
Phone: +41 31 389 93 91
Fax: +41 31 389 93 92

Date of Activation
October 3, 2003

Date of Closure
January 28, 2008

Targeted Accrual
385 patients

Final Accrual
394 patients (IBCSG 42)


News

21.05.2013:
A few impressions from our audits

10.04.2013:
New publications are available

19.03.2013:
The next  IBCSG Annual Meeting will take place in Glasgow, Scotland on March 21nd and 22th, 2014.

All News

 
  Print